Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Treating primary cicatricial alopecia is difficult and requires evidence-based methods.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Cacumen Platycladi extract can safely and effectively reduce hair loss and increase hair density.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.